Brief: QIAGEN And Lilly Collaborate To Support Development Of QIAstat-Dx IVD Panel
Sept 5 (Reuters) - QIAGEN NV QIA.DE :
* SAID ON WEDNESDAY: QIAGEN AND LILLY COLLABORATE TO SUPPORT
DEVELOPMENT OF QIASTAT-DX IVD PANEL THAT IDENTIFIES PATIENTS AT
RISK FOR DEVELOPING ALZHEIMER’S DISEASE
* COLLABORATION SET TO LAUNCH FIRST COMMERCIALLY AVAILABLE
IVD KIT
FOR APOE GENOTYPING
Source text for Workspace: urn:newsml:reuters.com:*:nGNE57pMjy
Further company coverage: QIA.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))